ParkinsonV1, Main, Curation, indexHead, KwdEn.i

Index : Keywords

Les termes de plus forte occurence

1301	Parkinson's disease
147	Parkinson’s disease
110	Parkinson disease
102	levodopa
100	dementia
96	deep brain stimulation
77	depression
74	dopamine
73	Alzheimer's disease
64	subthalamic nucleus
63	parkinsonism
59	genetics
58	epidemiology
48	multiple system atrophy
45	Parkinson
44	LRRK2
41	substantia nigra
39	neuroprotection
39	neurodegeneration
37	dyskinesia
36	quality of life
35	α‐synuclein
35	gait
33	progressive supranuclear palsy
33	basal ganglia
33	MPTP
32	dopamine agonists
32	PET
30	cognition
29	motor fluctuations
27	treatment
26	olfaction
26	magnetic resonance imaging
26	Wolff‐Parkinson‐White syndrome
25	Lewy bodies
24	essential tremor
24	SPECT
23	dementia with Lewy bodies
23	Parkinsonism
22	positron emission tomography
22	hallucinations
22	dyskinesias
22	dopamine agonist
22	MRI
22	Lewy body
21	prevalence
21	mortality
21	mitochondria
21	diagnosis
21	atrial fibrillation
21	Dopamine
21	Alzheimer disease
20	tremor
20	risk factors
20	psychosis
19	sleep
19	parkin
19	mutation
19	PINK1
19	PD
19	Huntington's disease
18	striatum
18	motor complications
18	freezing of gait
18	dystonia
18	dopamine transporter
18	cognitive impairment
18	alpha‐synuclein
18	UPDRS
18	Levodopa
17	rating scales
17	oxidative stress
17	movement disorders
17	entacapone
17	apomorphine
16	elderly
16	assessment
16	L‐dopa
15	progression
15	mild cognitive impairment
15	UPDRS = Unified Parkinson's Disease Rating Scale
14	smoking
14	rehabilitation
14	rasagiline
14	globus pallidus
14	Alzheimer’s disease
13	tyrosine hydroxylase
13	microglia
13	fatigue
13	falls
13	catheter ablation
13	association
13	anxiety
13	Lewy body disease
12	transcranial magnetic stimulation
12	neuropathology
12	disability
12	differential diagnosis
12	clinical trial
12	Substantia nigra
12	REM sleep behavior disorder
12	PD, Parkinson’s disease
11	systematic review
11	supraventricular tachycardia
11	selegiline
11	physical therapy
11	health‐related quality of life
11	exercise
11	bradykinesia
11	Neurodegeneration
11	6‐hydroxydopamine
10	voxel‐based morphometry
10	visual hallucinations
10	ubiquitin
10	therapy
10	restless legs syndrome
10	pramipexole
10	postural instability
10	neurodegenerative diseases
10	dysphagia
10	clinimetrics
10	clinical trials
10	cerebrospinal fluid
10	autonomic nervous system
10	arrhythmia
10	apathy
10	Striatum
10	Gaucher disease
10	Aging
9	wearing‐off
9	serotonin
9	ropinirole
9	review
9	proteasome
9	prognosis
9	pathological gambling
9	pallidotomy
9	nonmotor symptoms
9	meta‐analysis
9	inflammation
9	incidence
9	idiopathic Parkinson's disease
9	glucocerebrosidase
9	excessive daytime sleepiness
9	balance
9	aging
9	Unified Parkinson's Disease Rating Scale
9	Parkin
9	Basal ganglia
8	validity
8	transcranial sonography
8	polymorphism
8	pathogenesis
8	pain
8	orthostatic hypotension
8	neuropsychology
8	impulse control disorders
8	human
8	homocysteine
8	dysarthria
8	disease progression
8	diffusion‐weighted imaging
8	cell death
8	bromocriptine
8	biomarker
8	autonomic dysfunction
8	attention
8	apoptosis
8	accessory pathway
8	ablation
8	TH
8	Parkinson's
8	Parkinson's Disease
8	Huntington disease
8	Dementia
7	stroke
7	sleep disorders
7	preexcitation
7	parkinson's disease
7	neuropsychiatry
7	neurodegenerative disorders
7	monoamine oxidase
7	impulsivity
7	hyposmia
7	gambling
7	freezing
7	fMRI
7	diffusion tensor imaging
7	daytime sleepiness
7	constipation
7	cognitive function
7	coffee
7	apolipoprotein E
7	antipsychotics
7	amyotrophic lateral sclerosis
7	amygdala
7	UPDRS, Unified Parkinson’s Disease Rating Scale
7	SNCA
7	Positron emission tomography
7	Parkinson's disease dementia
7	PSP
7	Oxidative stress
7	ECG
7	Disorders of the nervous system
7	Deep brain stimulation
7	6‐OHDA
6	ventricular tachycardia
6	uric acid
6	transplantation
6	thalamotomy
6	synuclein
6	survival
6	surgery
6	smell
6	rotenone
6	reliability
6	rat
6	physiotherapy
6	norepinephrine
6	non‐motor symptoms
6	neurotoxicity
6	neurodegenerative disease
6	mobility
6	immunohistochemistry
6	family history
6	familial Parkinson's disease
6	executive functions
6	etiology
6	electrophysiology
6	dopaminergic neurons
6	continuous dopaminergic stimulation
6	cohort study
6	amyloid
6	amantadine
6	age at onset
6	aetiology
6	WPW
6	Tremor
6	Selegiline
6	STN, subthalamic nucleus
6	Motor fluctuations
6	HVA
6	Dyskinesias
6	Dementia with Lewy bodies
6	DBS
6	Bromocriptine
6	AV
5	working memory
5	tauopathies
5	sudden death
5	substantia nigra pars compacta
5	speech
5	safety
5	rotigotine
5	psychiatric symptoms
5	postural control
5	polysomnography
5	plasticity
5	placebo
5	pharmacotherapy
5	pergolide
5	pathophysiology
5	outcome
5	non‐motor
5	nonmotor
5	neurosurgery
5	motor impairment
5	motor control
5	monotherapy
5	mitochondrial DNA
5	linkage
5	leucine‐rich repeat kinase 2
5	kinase
5	iron
5	hippocampus
5	genetic
5	gene expression
5	executive function
5	dysautonomia
5	deprenyl
5	cluster analysis
5	cardiomyopathy
5	cancer
5	biomarkers
5	behavior
5	autonomic
5	autonomic failure
5	atypical parkinsonism
5	anticholinergics
5	ageing
5	Wolff–Parkinson–White syndrome
5	SPM = statistical parametric mapping
5	SNP
5	ROI = region of interest
5	Putamen
5	Progressive supranuclear palsy
5	Pergolide
5	Parkinson's disease (PD)
5	PDQ‐39
5	PARK2
5	Multiple system atrophy
5	Mitochondria
5	MRI, magnetic resonance imaging
5	Human
5	HPLC
5	Gait
5	G2019S
5	Epidemiology
5	Depression
5	DBS, deep brain stimulation
5	DA
5	COMT inhibition
5	6-OHDA
4	vision
4	ubiquitin‐proteasome system
4	thalamus
4	tau
4	synucleinopathy
4	symptoms
4	subthalamic nucleus stimulation
4	sleep disturbance
4	side‐effects
4	sialorrhea
4	serotonin transporter
4	screening
4	risk factor
4	repetitive transcranial magnetic stimulation
4	reaction time
4	quetiapine
4	questionnaire
4	putamen
4	psychometrics
4	proteomics
4	prospective study
4	proprioception
4	primates
4	prefrontal cortex
4	piribedil
4	pharmacokinetics
4	pharmacoepidemiology
4	penetrance
4	nursing home
4	neuropsychological
4	neurological disorders
4	neuroinflammation
4	neuroimaging
4	motor
4	motor symptoms
4	motor cortex
4	morbidity
4	monoamine oxidase inhibitors
4	microarray
4	memory
4	manganese
4	linkage disequilibrium
4	linkage analysis
4	levetiracetam
4	incidental Lewy body disease
4	imaging
4	human brain
4	homovanillic acid
4	hallucination
4	genetic testing
4	genes
4	gene therapy
4	gait variability
4	gait disorder
4	gait analysis
4	functional magnetic resonance imaging
4	functional imaging
4	function
4	frontotemporal dementia
4	fluctuations
4	evidence‐based medicine
4	drooling
4	disease severity
4	corticobasal degeneration
4	complex disease
4	complex I
4	cohort studies
4	cognitive
4	cognitive functions
4	cognitive deficits
4	clinical phenotype
4	clinical features
4	cerebellum
4	cell therapy
4	caffeine
4	brain atrophy
4	autosomal recessive parkinsonism
4	autopsy
4	atrophy
4	atrial flutter
4	asymmetry
4	astrocyte
4	arrhythmias
4	animal models
4	age of onset
4	activities of daily living
4	UPSIT
4	Tyrosine hydroxylase
4	Transplantation
4	Thalamotomy
4	Taiwanese
4	SMA = supplementary motor area
4	Rehabilitation
4	Prevalence
4	Pramipexole
4	Parkinson's disease/parkinsonism
4	Pallidotomy
4	PSP = progressive supranuclear palsy
4	PRKN
4	PARK8
4	Neural transplantation
4	NMDA
4	Magnetic resonance imaging
4	MSA
4	MMSE = Mini-Mental State Examination
4	MIBG scintigraphy
4	L‐DOPA
4	Lewy body dementia
4	Huntington’s disease
4	HD
4	Genetics
4	GPi = globus pallidus internus
4	Electromyography
4	Dopamine agonist
4	DOPAC
4	DLB = dementia with Lewy bodies
4	DJ‐1
4	Cognition
4	Cerebrospinal fluid
4	Caudate nucleus
4	Cabergoline
4	CFT
4	BA = Brodmann area
4	AVNRT
4	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
3	α-synuclein
3	α-Synuclein
3	women
3	wearing off
3	visual hallucination
3	variant
3	urodynamics
3	tyramine
3	transgenic mouse
3	test–retest reliability
3	synucleinopathies
3	synchronization
3	swallowing
3	suicide
3	sudden cardiac death
3	subthalamic
3	subthalamic stimulation
3	stimulation
3	stereotaxy
3	stem cell
3	staging
3	sporadic
3	speech therapy
3	speech disorder
3	spectroscopy
3	somatosensory evoked potential
3	single photon emission computed tomography (SPECT)
3	signal transduction
3	reward
3	reactive oxygen species
3	rTMS
3	rCBF = regional cerebral blood flow
3	punding
3	psychometric properties
3	psychiatry
3	protein aggregation
3	promoter
3	primate
3	population‐based
3	population
3	polymorphisms
3	phosphorylation
3	pharmacology
3	pediatrics
3	pathology
3	parkinsonian disorders
3	oxidative phosphorylation
3	oxidative damage
3	outcomes research
3	outcome measures
3	osteoporosis
3	olfactory bulb
3	nutrition
3	nursing
3	nucleus accumbens
3	nitric oxide
3	nicotine
3	neurotrophic factors
3	neurophysiology
3	neurology
3	neuroleptics
3	neural transplantation

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/Parkinson.storage/ParkinsonV1/Data/Main/Curation/KwdEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024

	Serveur d'exploration sur la maladie de Parkinson - Curation (Accueil) Index « Mots-clés originaux en anglais » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la maladie de Parkinson - Curation (Accueil)Index « Mots-clés originaux en anglais » - tête de navigation

Index : Keywords

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration sur la maladie de Parkinson - Curation (Accueil)

Index « Mots-clés originaux en anglais » - tête de navigation